Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jawed Fareed

Showing results (191-200 of 393) with videos related to

Pageof 40
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 23, 2024
Angiopoietin-2 and Mortality Outcomes in End-Stage Renal Disease with Heart Failure as a ComorbidityVanessa Robbin, Vinod Bansal, Kavitha Vellanki, et al.
Hematology/Oncology Clinics of North America|January 22, 2008
Laboratory evaluation of the antiphospholipid syndromeDebra A Hoppensteadt, Nancy Fabbrini, Rodger L Bick, et al.
Hematology/Oncology Clinics of North America|January 11, 2005
Development of generic low molecular weight heparins: a perspectiveJawed Fareed, Wendy Leong, Debra A Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 26, 2005
Generic low molecular weight heparins: a significant dilemmaJawed Fareed, Omer Iqbal, Helena Nader, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 5, 2009
Inflammatory biomarker profiling in elderly patients with acute hip fracture treated with heparinsMichael John Knesek, Evangelos Litinas, Cafer Adiguzel, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2005
Functional characterization of antibodies against heparin-platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian-Indians: relevance to inflammatory markersMeganathan Kannan, Sarfraz Ahmad, Firdos Ahmad, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 8, 2011
Functionality of fondaparinux (pentasaccharide) depends on clinical antithrombin levelsWalter P Jeske, Jeanine M Walenga, Meyer M Samama, et al.
European Journal of Pharmacology|June 25, 2002
Low molecular weight glycosaminoglycan blockade of beta-amyloid induced neuropathologyMark Walzer, Stanley Lorens, Matthew Hejna, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 21, 2012
Assessment of HIT antibody complex in hip fracture patients receiving enoxaparin or unfractionated heparinJustin W Griffin, William J Hopkinson, Michael R Lassen, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 16, 2020
Targeted, Site-Specific, Delivery Vehicles of Therapeutics for COVID-19 Patients. Brief ReviewNicholas Kipshidze, Patrick Iversen, Thomas R Porter, et al.
Pageof 40

Showing results (191-200 of 393) with videos related to

Sort By:
Pageof 40
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 23, 2024
Angiopoietin-2 and Mortality Outcomes in End-Stage Renal Disease with Heart Failure as a ComorbidityVanessa Robbin, Vinod Bansal, Kavitha Vellanki, et al.
Hematology/Oncology Clinics of North America|January 22, 2008
Laboratory evaluation of the antiphospholipid syndromeDebra A Hoppensteadt, Nancy Fabbrini, Rodger L Bick, et al.
Hematology/Oncology Clinics of North America|January 11, 2005
Development of generic low molecular weight heparins: a perspectiveJawed Fareed, Wendy Leong, Debra A Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 26, 2005
Generic low molecular weight heparins: a significant dilemmaJawed Fareed, Omer Iqbal, Helena Nader, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 5, 2009
Inflammatory biomarker profiling in elderly patients with acute hip fracture treated with heparinsMichael John Knesek, Evangelos Litinas, Cafer Adiguzel, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2005
Functional characterization of antibodies against heparin-platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian-Indians: relevance to inflammatory markersMeganathan Kannan, Sarfraz Ahmad, Firdos Ahmad, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 8, 2011
Functionality of fondaparinux (pentasaccharide) depends on clinical antithrombin levelsWalter P Jeske, Jeanine M Walenga, Meyer M Samama, et al.
European Journal of Pharmacology|June 25, 2002
Low molecular weight glycosaminoglycan blockade of beta-amyloid induced neuropathologyMark Walzer, Stanley Lorens, Matthew Hejna, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 21, 2012
Assessment of HIT antibody complex in hip fracture patients receiving enoxaparin or unfractionated heparinJustin W Griffin, William J Hopkinson, Michael R Lassen, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 16, 2020
Targeted, Site-Specific, Delivery Vehicles of Therapeutics for COVID-19 Patients. Brief ReviewNicholas Kipshidze, Patrick Iversen, Thomas R Porter, et al.
Pageof 40